Research output per year
Research output per year
Personal profile
Headline
ADJUNCT PROFESSOR
Fingerprint
Dive into the research topics where Dale Lange is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study
MG0003 study team, May 2023, In: The Lancet Neurology. 22, 5, p. 383-394 12 p.Research output: Contribution to journal › Article › peer-review
7 Scopus citations -
Cell environment shapes TDP-43 function with implications in neuronal and muscle disease
NYGC ALS Consortium, Dec 2022, In: Communications Biology. 5, 1, 314.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations -
NOS1AP is a novel molecular target and critical factor in TDP-43 pathology
NYGC ALS Consortium, 2022, In: Brain Communications. 4, 5Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
NYGC ALS Consortium, 3 Mar 2022, In: Nature. 603, 7899, p. 131-137 7 p.Research output: Contribution to journal › Article › peer-review
Open Access93 Scopus citations -
An integrated multi-omic analysis of iPSC-derived motor neurons from C9ORF72 ALS patients
The NeuroLINCS Consortium & NYGC ALS Consortium, 19 Nov 2021, In: iScience. 24, 11, 103221.Research output: Contribution to journal › Article › peer-review
Open Access14 Scopus citations
Press/Media
-
-
-
-
SOD1 Inhibition by Pyrimethamine in Familial Amyotrophic Lateral Sclerosis (ALS)
2/10/18
1 item of Media coverage
Press/Media
-